文献速递神经肌肉病

加快肌萎缩侧索硬化的诊断

Hastening the Diagnosis of Amyotrophic Lateral Sclerosis.
PubMed 文献 · Neurology · 2022-07-11

肌萎缩侧索硬化(ALS)从症状出现到确诊约需12个月,而神经退行性过程在症状前即已活跃。文章汇总了Gold Coast标准、基因检测及脑脊液/血清神经丝轻链水平支持诊断的II类证据,并针对基层识别与神经科医生加速诊断提出多项建议。

要点

  • ALS从新发进行性无力到确诊约需12个月,症状前运动神经元已丢失约20%。
  • Gold Coast标准与基因检测是现有可用的早期诊断工具。
  • 至少2项II类证据支持脑脊液和/或血清神经丝水平辅助ALS诊断。

核心结论

  • 加快ALS诊断可更早启动延缓神经退行性过程的治疗并早期开展多学科照护。
  • 文章提出多项建议以促进基层医生早期识别可能的ALS并增强神经科医生加速诊断的紧迫感。

研究设计与样本

  • 本文为综述,汇总ALS早期诊断相关证据并提出建议。

主要发现

  • 从新发进行性无力到确诊ALS约需12个月。
  • 在症状前阶段,人体尸检研究显示前根运动神经元已丢失约20%。
  • 日后发展为ALS者及携带致病基因变异的症状前家系成员血清神经丝水平高。
  • 利鲁唑、依达拉奉、甲钴胺和苯丁酸钠-牛磺熊去氧胆酸在患者照护和临床试验中显示早期治疗可延缓神经退行性过程。
  • 早期启动多学科照护可节省费用并延长生存,早期诊断似乎可减轻心理痛苦。

关键数值与推荐

  • Gold Coast标准为新的简易ALS诊断标准,已与基因检测一同引入。
  • 至少2项研究提供II类证据,确立脑脊液和/或血清神经丝水平支持ALS诊断的可靠性和敏感性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Amyotrophic lateral sclerosis (ALS) is a chronic progressive neurodegenerative disease. Neurologists generally see patients as requested and as schedules allow. This practice is part of the reason it takes approximately 12 months from onset of new progressive weakness to receive a definitive diagnosis of ALS. It is well recognized that the disease of ALS starts long before symptom onset. In mutant SOD1 transgenic mice, early loss of motor neurons and compensatory morphological changes precede a rapid loss of motor neurons that coincides with symptom onset. In a human autopsy study, anterior roots in the "presymptomatic" stage indicate that ∼20% loss of motor neurons had already occurred. Sera collected from individuals who later developed ALS and sera from presymptomatic members of families with ALS harboring pathogenic gene variants demonstrated high neurofilament (Nf) levels, again suggesting that the neurodegenerative process is already active at a clinically presymptomatic stage. Potential benefits of hastening the diagnosis of ALS include earlier initiation of therapy to slow the fundamental neurodegenerative process. Such effects are observed in treatment with riluzole, edaravone, methylcobalamin, and sodium phenylbutyrate-taurursodiol in patient care and clinical trial settings. Early initiation of multidisciplinary care results in cost savings and prolonged survival. Early diagnosis after symptom onset also seems to reduce psychological distress. Hence, how can we facilitate an earlier diagnosis of ALS? We already have the necessary tools. New and simple ALS diagnostic criteria (Gold Coast Criteria) have been introduced along with genetic testing. At least 2 studies provide Class II evidence that establishes the reliability and sensitivity of CSF and/or serum Nf levels in supporting a diagnosis of ALS. Challenges, however, still exist as to how to facilitate earlier recognition of possible ALS by primary care physicians and other nonneurologist providers and how to foster a sense of urgency among neurologists to accelerate the diagnostic process. In this article, we provide a number of recommendations that we hope will help achieve these ends.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Mitsumoto H, Kasarskis EJ, Simmons Z, et al. Hastening the Diagnosis of Amyotrophic Lateral Sclerosis. Neurology. 2022. PMID: 35577578. doi:10.1212/WNL.0000000000200799

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。